Epileptiform Seizure After Sertraline Treatment in an Adolescent Experiencing Obsessive-Compulsive Disorder and Presenting a Rare Pharmacogenetic Status-Reference-Cited by-同舟云学术

Epileptiform Seizure After Sertraline Treatment in an Adolescent Experiencing Obsessive-Compulsive Disorder and Presenting a Rare Pharmacogenetic Status

Published:2006-12 Issue:6 Volume:26 Page:679-681
ISSN:0271-0749
Container-title:Journal of Clinical Psychopharmacology
language:en
Short-container-title:

Author:

Baumann Pierre,Barbe Rémy,Vabre-Bogdalova Assia,Garran Encarni,Crettol Séverine,Eap Chin B.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Psychiatry and Mental health

Reference26 articles.

1. Long-term sertraline treatment of children and adolescents with obsessive-compulsive disorder.;Cook;J Am Acad Child Adolesc Psychiatry,2001

2. Sertraline treatment of children and adolescents with obsessive-compulsive disorder or depression: pharmacokinetics, tolerability, and efficacy.;Alderman;J Am Acad Child Adolesc Psychiatry,1998

3. Sertraline in children and adolescents with obsessive-compulsive disorder-a multicenter randomized controlled trial.;March;JAMA,1998

4. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study POTS. Randomized controlled trial.;JAMA,2004

5. The disposition of fluoxetine but not sertraline is altered in poor metabolizers of debrisoquin.;Hamelin;Clin Pharmacol Ther,1996

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adverse Drug Reactions of Olanzapine, Clozapine and Loxapine in Children and Youth: A Systematic Pharmacogenetic Review;Pharmaceuticals;2022-06-14

2. Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants;The World Journal of Biological Psychiatry;2021-05-12

3. The Molecular Genetics of Obsessive-Compulsive and Related Disorders;A Transdiagnostic Approach to Obsessions, Compulsions and Related Phenomena;2019-01-03

4. Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017;Pharmacopsychiatry;2017-09-14

5. The pharmacogenetic road to avoid adverse drug reactions and therapeutic failures in revolving door patients with psychiatric illnesses: focus on the CYP2D6 isoenzymes;Expert Review of Precision Medicine and Drug Development;2016-09-02